Indegene Ltd (NSE:INDGN) Share Price

Company Profile

Business description
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.
Contact
Outer Ring Road
Aspen Block G4, 3rd Floor
Manyata Embassy Business Park
Nagawara
BengaluruKA560045
IND
T: +91 8046744567
https://www.indegene.com
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 March 2026
Employees
5,181

Recommended

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.

Malik Ahmed Khan, CFA | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	9,015.40	48.70	0.54%
CAC 40	7,861.96	4.60	0.06%
DAX 40	24,262.22	44.85	0.19%
Dow JONES (US)	44,461.28	171.71	-0.38%
FTSE 100	9,136.94	0.62	0.01%
HKSE	25,176.93	347.52	-1.36%
NASDAQ	21,129.67	31.38	0.15%
Nikkei 225	40,654.70	19.85	-0.05%
NZX 50 Index	12,865.93	9.96	0.08%
S&P 500	6,362.90	7.96	-0.12%
S&P/ASX 200	8,756.40	51.80	0.60%
SSE Composite Index	3,615.72	6.01	0.17%